Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: RSV MEDI ΔM2-2 vaccineBiological: Placebo vaccine
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2015-12-15
- Target Recruit Count
- 60
- Registration Number
- NCT01459198
- Locations
- 🇺🇸
John Hopkins Center for Immunization Research, Baltimore, Maryland, United States
Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
- Conditions
- H5N1 Influenza
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2019-12-16
- Target Recruit Count
- 96
- Registration Number
- NCT01443936
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
- Conditions
- HIV/AIDSHepatitis
- Interventions
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2015-07-13
- Target Recruit Count
- 4
- Registration Number
- NCT01443923
- Locations
- 🇺🇸
Unity Health Care, Inc./DC General, Washington, DC, District of Columbia, United States
🇺🇸National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
- Conditions
- H5N1 Influenza
- Interventions
- Biological: H5N1 Vaccine
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2016-02-09
- Target Recruit Count
- 69
- Registration Number
- NCT01443663
- Locations
- 🇺🇸
Centers for Immunization Research (CIR) - John Hopkins Bloomburg School of Public Health, Baltimore, Maryland, United States
Chloroquine for Malaria in Pregnancy
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2016-12-28
- Target Recruit Count
- 900
- Registration Number
- NCT01443130
- Locations
- 🇲🇼
Blantyre Malaria Project - Queen Elizabeth Central Hospital, Blantryre, Blantyre, Malawi
Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women
- Conditions
- Pneumococcal InfectionsHIV Infections
- Interventions
- Biological: PPV-23 VaccineBiological: PCV-13 VaccineBiological: Placebo Vaccine
DAS181 in Patients With Parainfluenza
GS-7977 With Ribavirin for Hepatitis C (SPARE)
- First Posted Date
- 2011-09-27
- Last Posted Date
- 2014-09-26
- Target Recruit Count
- 60
- Registration Number
- NCT01441180
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Experimental PfSPZ Vaccine in Adults Without Malaria
- Conditions
- Acquired ImmunityPrevention and ControlMalaria
- First Posted Date
- 2011-09-27
- Last Posted Date
- 2018-07-05
- Target Recruit Count
- 64
- Registration Number
- NCT01441167
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults
- Conditions
- HIV Infections
- Interventions
- Biological: Placebo injection (normal saline)Biological: VSV-Indiana HIV gag vaccine
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2021-10-15
- Target Recruit Count
- 60
- Registration Number
- NCT01438606
- Locations
- 🇺🇸
Bridge HIV CRS, San Francisco, California, United States
🇺🇸The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States
🇺🇸Penn Prevention CRS, Philadelphia, Pennsylvania, United States